Brighton Jones LLC acquired a new position in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,343 shares of the health services provider’s stock, valued at approximately $225,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in shares of Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares during the last quarter. Vanguard Group Inc. increased its position in Cigna Corporation by 3.5% in the first quarter. Vanguard Group Inc. now owns 16,706,266 shares of the health services provider’s stock valued at $2,447,301,000 after buying an additional 570,241 shares during the period. State Street Corp increased its position in Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock valued at $1,631,451,000 after buying an additional 190,323 shares during the period. Wellington Management Group LLP increased its position in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares during the period. Finally, Boston Partners increased its position in Cigna Corporation by 3.1% in the first quarter. Boston Partners now owns 3,604,693 shares of the health services provider’s stock valued at $528,052,000 after buying an additional 108,880 shares during the period. Institutional investors own 87.95% of the company’s stock.

Shares of Cigna Corporation (CI) opened at 180.09 on Wednesday. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $181.15. The stock has a market cap of $45.34 billion, a price-to-earnings ratio of 20.78 and a beta of 0.46. The stock’s 50 day moving average is $175.07 and its 200 day moving average is $161.41.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The company had revenue of $10.32 billion during the quarter, compared to analysts’ expectations of $10.26 billion. During the same period last year, the firm earned $1.98 EPS. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, equities analysts predict that Cigna Corporation will post $10.02 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Brighton Jones LLC Acquires Shares of 1,343 Cigna Corporation (CI)” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://theolympiareport.com/2017/08/30/brighton-jones-llc-acquires-shares-of-1343-cigna-corporation-ci.html.

Several research analysts have commented on CI shares. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price target on shares of Cigna Corporation in a research note on Thursday, June 8th. Stifel Nicolaus lifted their target price on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Deutsche Bank AG lifted their target price on shares of Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, May 10th. UBS AG reaffirmed a “buy” rating and issued a $186.00 target price (up from $181.00) on shares of Cigna Corporation in a research note on Monday, June 5th. Finally, ValuEngine raised shares of Cigna Corporation from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $180.44.

In related news, insider Michael W. Triplett sold 1,439 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $166.89, for a total value of $240,154.71. Following the completion of the transaction, the insider now directly owns 26,199 shares of the company’s stock, valued at approximately $4,372,351.11. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jason D. Sadler sold 1,727 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $164.59, for a total value of $284,246.93. Following the completion of the transaction, the insider now directly owns 34,504 shares of the company’s stock, valued at $5,679,013.36. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,008 shares of company stock valued at $39,828,200. Company insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.